Prime Minister Jacinda Ardern admitted Monday that New Zealand's widely praised 'Covid zero' strategy had failed to halt a stubborn outbreak in Auckland and said a new approach was needed.
Prime Minister Jacinda Ardern admitted Monday that New Zealand's widely praised "Covid zero" strategy had failed to halt a stubborn outbreak in Auckland and said a new approach was needed.
But an August outbreak prompted a seven-week lockdown in its main population centre that has failed to curb infection rates. She added that the change -- a major shift to her previous goal of completely stamping out the virus -- was possible because vaccination rates had increased dramatically. Auckland will remain in lockdown for now but the government will conduct weekly reviews to time the reintroduction of freedoms.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
An Unpredictable COVID-19 Situation Creates New Challenges for Race Directors This FallRegistration numbers are low, while emotions are running high.
Lire la suite »
New Zealand Gives Up On ‘Zero Covid’ Strategy Amid Persistent Delta Variant OutbreakAcknowledging the delta variant as a “game-changer,” New Zealand Prime Minister Jacinda Ardern said it could not be eliminated even with long-term restrictions.
Lire la suite »
Fauci says new pill 'impressive' at keeping COVID patients alive and out of hospitalsA new pill to treat COVID-19 has shown “impressive” results in clinical trials, Dr. Anthony Fauci said during a Friday briefing of the White House pandemic response team. The drug, molnupiravir, is an antiviral treatment developed by Merck in conjunction with Ridgeback Biotherapeutics.
Lire la suite »
As Vaccination Numbers Continue to Stall, a New COVID Antiviral Pill Might Be Coming SoonThe oral antiviral from Merch and Ridgeback Biotherapeutics can reduce the risk of death and hospitalization by as much as 50 percent, its makers say.
Lire la suite »
Japan stocks set to rise after Merck announces new Covid treatment; China markets closedMerck and Ridgeback Biotherapeutics announced Friday they’ve developed a drug which reduces the risk of hospitalization or death by around 50% in Covid patients.
Lire la suite »
China reports 27 new COVID-19 cases, down from 28 a day earlierChina reported 27 new COVID-19 cases on the mainland for Oct. 3, down from 28 a day earlier, the national health authority said on Monday.
Lire la suite »